Related Experiment Videos
Oxidative stress induced by glutamate receptor agonists
1Department of Community and Environmental Medicine, University of California, Irvine 92717.
Brain Research
|May 7, 1993
Summary
Selective glutamate agonists, particularly kainate, increase reactive oxygen species (ROS) generation in rat brain microsacs. This suggests a role for glutamate in neurological damage independent of ionotropic receptor activity.
Area of Science:
- Neuroscience
- Biochemistry
- Cellular Biology
Background:
- Glutamate is a key excitatory neurotransmitter in the central nervous system.
- Reactive oxygen species (ROS) are implicated in various neurological disorders and damage.
- Understanding the interplay between glutamate signaling and ROS production is crucial for neuroprotection research.
Purpose of the Study:
- To investigate the impact of selective glutamate agonists on ROS generation in rat cerebral cortex synaptoneurosomes.
- To determine if glutamate's effect on ROS is mediated through ionotropic receptors.
- To explore potential mechanisms linking glutamate activity to oxidative stress in the brain.
Main Methods:
- Isolated synaptoneurosomal fraction from rat cerebral cortex was used.
- Rates of ROS generation were measured using a fluorescent probe.
- Selective agonists for NMDA, kainate, and AMPA receptors were applied.
- Metabotropic glutamate agonist (ACPD) and ion-channel agents were tested.
Main Results:
- NMDA, kainate, and AMPA receptor agonists significantly enhanced ROS generation.
- Kainate showed the most pronounced stimulation of ROS.
- The metabotropic glutamate agonist ACPD did not affect ROS levels.
- Domoic acid, a kainate agonist, also increased ROS generation.
- Results were not replicated by ion-channel active agents; kainate-induced ROS was not blocked by CNQX.
Conclusions:
- Selective glutamate agonists can increase ROS generation in brain microsacs.
- This effect appears to be independent of ionotropic receptor channel activity.
- Glutamate agonists may contribute to neurological damage through mechanisms involving ROS production.